Baseline Laboratory Assessment Before initiating GHK-Cu therapy, obtain: Serum copper level (normal range: 70 to 140 mcg/dL) Ceruloplasmin (normal range: 20 to 35 mg/dL) 24-hour urine copper (to exclude copper overload states) Hepatic function panel (AST, ALT, alkaline phosphatase, total bilirubin) Complete blood count with differential Wound photography and planimetric measurement (length, width, area) Wound culture if signs of infection are present Patients with Wilson disease, known copper storage disorders, or hepatic cirrhosis should not receive exogenous copper peptides [13]
Protective Effect of Standardized Extract of Ginkgo biloba against Cisplatin-Induced Nephrotoxicity
Mettl17, a regulator of mitochondrial ribosomal RNA modifications, is required for the translation of mitochondrial coding genes
What are the safest and most effective GSH supplements
We have written extensively about what BPC-157 actually does and the body protective compound clinical applications, and the short version is that the strongest evidence supports tendon and ligament repair, gut-lining integrity, and reduction of NSAID-related tissue damage
Related studies mainly focus on in vivo intervention efficacy validation, exploration of combined intervention strategies, and optimization of pharmaceutical dosage forms, providing important experimental evidence for clinical intervention of obesity